Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in CRPC Post-Taxotere
NCT01481233Phase 2Withdrawn
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- May 2013
- Primary completion
- Aug 2013
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
01
Overview
A Phase 2 trial of colchicine in prostate cancer (PCa), sponsored by Penn State Health Milton S. Hershey Medical Center. Planned start May 2013; status: withdrawn.
02
Drugs
colchicine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01481233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01481233.